Inventor · disambiguated record
Georg Dahmann
Also filed as: DAHMANN GEORG
58 granted patents·40 pending applications·344 citations·filing 1995–2025
98Inventor score
Files withBOEHRINGER INGELHEIM INT55GOTTSCHLING DIRK7BOEHRINGER INGELHEIM PHARMA6DAHMANN GEORG6GRAUERT MATTHIAS4
Top patents by PatentIndex Score
98 records- 0196US10154990B2Medicaments for the treatment or prevention of fibrotic diseasesBOEHRINGER INGELHEIM INT·Filed 2015·Granted Dec 18, 2018·15 cites·5 claims
- 0296US7173028B2Pyrimidine derivativesBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Feb 6, 2007·116 cites·11 claims
- 0393US11578080B2ThienopyrimidonesBOEHRINGER INGELHEIM INT·Filed 2021·Granted Feb 14, 2023·2 cites·33 claims
- 0492US8110575B2CompoundsGOTTSCHLING DIRK·Filed 2008·Granted Feb 7, 2012·30 cites·20 claims
- 0590US11136336B2ThienopyrimidonesBOEHRINGER INGELHEIM INT·Filed 2020·Granted Oct 5, 2021·2 cites·12 claims
- 0688US12065427B2Heterocyclic compounds capable of activating STINGBOEHRINGER INGELHEIM INT·Filed 2022·Granted Aug 20, 2024·1 cites·40 claims
- 0788US7709480B2Pyrimidine derivativesBOEHRINGER INGELHEIM PHARMA·Filed 2005·Granted May 4, 2010·12 cites·12 claims
- 0885US2023372297A1Medicaments for the treatment or prevention of fibrotic diseasesBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 0984US8889677B2Substituted triazoles useful as mGlu5 receptor modulatorsGRAUERT MATTHIAS·Filed 2013·Granted Nov 18, 2014·8 cites·10 claims
- 1084US8093266B2Rho kinase inhibitorsDAHMANN GEORG·Filed 2008·Granted Jan 10, 2012·8 cites·11 claims
- 1184US7371743B2Carboxylic acid amides, the preparation thereof and their use as medicamentsBOEHRINGER INGELHEIM INT·Filed 2005·Granted May 13, 2008·5 cites·42 claims
- 1283US9845314B2Pyrazolyl-substituted heteroaryls and their use as medicamentsBOEHRINGER INGELHEIM INT·Filed 2016·Granted Dec 19, 2017·4 cites·31 claims
- 1382US8420630B2Pyrimidine derivativesDAHMANN GEORG·Filed 2010·Granted Apr 16, 2013·6 cites·12 claims
- 1481US7732466B2Substituted thiophene carboxamides, process for their preparation and their use as medicamentsBOEHRINGER INGELHEIM INT·Filed 2005·Granted Jun 8, 2010·5 cites·14 claims
- 1580US8772305B2Substituted pyridinyl-pyrimidines and their use as medicamentsDAHMANN GEORG·Filed 2012·Granted Jul 8, 2014·7 cites·22 claims
- 1679US10849907B2Imidazopyridine derivatives and the use thereof as medicamentBOEHRINGER INGELHEIM INT·Filed 2018·Granted Dec 1, 2020·1 cites·49 claims
- 1779US8642774B2CompoundsGRAUERT MATTHIAS·Filed 2012·Granted Feb 4, 2014·5 cites·11 claims
- 1878US7947700B2Carboxylic acid amides, the preparation thereof and their use as medicamentsBOEHRINGER INGELHEIM INT·Filed 2007·Granted May 24, 2011·2 cites·17 claims
- 1977US8450327B2CGRP antagonistsGOTTSCHLING DIRK·Filed 2008·Granted May 28, 2013·3 cites·23 claims
- 2077US2010204211A1Medicaments for the treatment or prevention of fibrotic diseasesBOEHRINGER INGELHEIM INT·Filed 2009·Application pending·0 cites
- 2176US7615549B2Substituted pyrrolidinones, their manufacture and their use as medicamentsBOEHRINGER INGELHEIM INT·Filed 2005·Granted Nov 10, 2009·2 cites·11 claims
- 2276US7326791B2Carboxylic acid amides, the preparation thereof, and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Feb 5, 2008·8 cites·4 claims
- 2375US8445525B2Carboxylic acid amides, the preparation thereof and their use as medicamentsPRIEPKE HENNING·Filed 2010·Granted May 21, 2013·2 cites·27 claims
- 2474US12421218B2Substituted pyrazine-carboxamide derivativesBOEHRINGER INGELHEIM INT·Filed 2024·Granted Sep 23, 2025·0 cites·14 claims
- 2574US8912173B2Substituted quinolines and their use as medicamentsHOFFMANN MATTHIAS·Filed 2012·Granted Dec 16, 2014·3 cites·35 claims
- 2673US8309542B2Substituted pyrrolidine amides, the production thereof, and the use thereof as medicationsGERLACH KAI·Filed 2008·Granted Nov 13, 2012·2 cites·10 claims
- 2772US5707989APyrimido 5,4-D!pyrimidines, medicaments comprising these compounds, their use and processes for their preparationTHOMAE GMBH DR K·Filed 1995·Granted Jan 13, 1998·40 cites·11 claims
- 2872US2019038600A1Medicaments for the treatment or prevention of fibrotic deiseasesBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 2971US8969568B2Substituted naphthyridines and their use as medicamentsHOFFMANN MATTHIAS·Filed 2011·Granted Mar 3, 2015·2 cites·16 claims
- 3071US2024270718A1Heterocyclic compounds capable of activating stingBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 3171US2020330435A1Medicaments for the treatment or prevention of fibrotic diseasesBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 3269US2014296217A1Medicaments for the treatment or prevention of fibrotic diseasesPARK JOHN EDWARD·Filed 2014·Application pending·0 cites
- 3368US5977102APyrimido [5, 4-d] pyrimidines, pharmaceuticals containing these compounds, their use and processes for their preparationTHOMAE GMBH DR K·Filed 1997·Granted Nov 2, 1999·31 cites·13 claims
- 3468US2025059165A1Piperidinylpyridinylcarbonitrile derivatives as inhibitors of glutaminyl-peptide cyclotransferase and glutaminyl-peptide cyclotransferase like proteinBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 3568US2025059166A1Piperidinylpyridinylcarbonitrile derivatives as inhibitors of glutaminyl-peptide cyclotransferase and glutaminyl-peptide cyclotransferase like proteinBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 3668US2025066329A1Piperidinylpyridinylcarbonitrile derivatives as inhibitors of glutaminyl-peptide cyclotransferase and glutaminyl-peptide cyclotransferase like proteinBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 3767US2024174652A1Novel dioxane derivativesBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 3867US2024182453A1Novel substituted pyrazine-carboxamide derivativesBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 3967US2024317712A1Phenylpiperidine derivatives as inhibitors of glutaminyl-peptide cyclotransferase and glutaminyl-peptide cyclotransferase like proteinBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 4066US8883789B2Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptorsHEIMANN ANNEKATRIN·Filed 2012·Granted Nov 11, 2014·2 cites·13 claims
- 4166US2006142373A1Medicaments for the Treatment or Prevention of Fibrotic DiseasesBOEHRINGER INGELHEIM INT·Filed 2005·Application pending·0 cites
- 4266US2024246981A1Phenylpiperidine derivatives as inhibitors of glutaminyl-peptide cyclotransferase and glutaminyl-peptide cyclotransferase like proteinBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 4365US11878981B2Substituted 1,2,4-oxadiazoles as TRPA1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2022·Granted Jan 23, 2024·0 cites·13 claims
- 4465US10947243B2Heteroaryl SYK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Mar 16, 2021·0 cites·2 claims
- 4565US2024059675A1Piperidinylpyridinylcarbonitrile derivatives as inhibitors of glutaminyl-peptide cyclotransferase and glutaminyl-peptide cyclotransferase like proteinBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 4665US2024174642A1Heterocyclic compounds capable of activating stingBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 4765US2024174641A1Heterocyclic compounds capable of activating stingBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 4864US8653087B2Pyrido [5, 4-D] pyrimidines as cell proliferation inhibitorsMANTOULIDIS ANDREAS·Filed 2009·Granted Feb 18, 2014·1 cites·13 claims
- 4963US2024166629A1Heterocyclic compounds capable of activating stingBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 5062US12497401B2Substituted tetrazoles as TRPA1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2020·Granted Dec 16, 2025·0 cites·7 claims
Showing the top 50 of 98 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Georg Dahmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →